TY - JOUR
T1 - Rational synthesis of rare-earth lanthanum molybdate covered reduced graphene oxide nanocomposites for the voltammetric detection of Moxifloxacin hydrochloride
AU - Akilarasan, Muthumariappan
AU - Tamilalagan, Elayappan
AU - Chen, Shen Ming
AU - Maheshwaran, Selvarasu
AU - Fan, Chih Hsuan
AU - Habila, Mohamed A.
AU - Sillanpää, Mika
N1 - Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/8
Y1 - 2022/8
N2 - Recently, perovskite structure-based metal oxide nanomaterials and their composites opted for electrocatalyst because of its excellent conductivity, unique, and favored electronic structure. In this attempt, herein we prepared the rare earth mixed metal molybdate covered reduced graphene oxide La2(MoO4)3@rGO nanocomposites by a simple hydrothermal method for the sensitive detection of Moxifloxacin hydrochloride (MOF) in pharmaceutical and human urine samples. The various physicochemical analysis such as SEM, TEM, XRD and Raman spectroscopy confirms the successful formation of (La2(MoO4)3@rGO) nanocomposites. Furthermore, the electroanalytical performance of La2(MoO4)3@rGO modified glassy carbon electrode (La2(MoO4)3@rGO/GCE) was analyzed using the cyclic voltammetry (CV) and differential pulse voltammetry (DPV) which shows excellent results with a wide range of 1.0 × 10−8 M to 6.0 × 10−4 M and the detection limit of 2.84 × 10−9 M towards the MOF detection. Furthermore, the developed sensor expressed good selectivity, repeatability, stability and reproducibility. Finally, the real sample analysis of the developed sensor was tested in the MOF tablets and human urine samples, which shows the appreciable recoveries.
AB - Recently, perovskite structure-based metal oxide nanomaterials and their composites opted for electrocatalyst because of its excellent conductivity, unique, and favored electronic structure. In this attempt, herein we prepared the rare earth mixed metal molybdate covered reduced graphene oxide La2(MoO4)3@rGO nanocomposites by a simple hydrothermal method for the sensitive detection of Moxifloxacin hydrochloride (MOF) in pharmaceutical and human urine samples. The various physicochemical analysis such as SEM, TEM, XRD and Raman spectroscopy confirms the successful formation of (La2(MoO4)3@rGO) nanocomposites. Furthermore, the electroanalytical performance of La2(MoO4)3@rGO modified glassy carbon electrode (La2(MoO4)3@rGO/GCE) was analyzed using the cyclic voltammetry (CV) and differential pulse voltammetry (DPV) which shows excellent results with a wide range of 1.0 × 10−8 M to 6.0 × 10−4 M and the detection limit of 2.84 × 10−9 M towards the MOF detection. Furthermore, the developed sensor expressed good selectivity, repeatability, stability and reproducibility. Finally, the real sample analysis of the developed sensor was tested in the MOF tablets and human urine samples, which shows the appreciable recoveries.
KW - Binary-metal oxide
KW - Drug analysis
KW - Electrochemical sensor
KW - La(MoO)@rGO nanocomposites
KW - Moxifloxacin hydrochloride sensor
UR - http://www.scopus.com/inward/record.url?scp=85129897280&partnerID=8YFLogxK
U2 - 10.1016/j.bioelechem.2022.108145
DO - 10.1016/j.bioelechem.2022.108145
M3 - Article
C2 - 35550254
AN - SCOPUS:85129897280
SN - 1567-5394
VL - 146
JO - Bioelectrochemistry
JF - Bioelectrochemistry
M1 - 108145
ER -